1017259--3/12/2008--NMT_MEDICAL_INC

related topics
{product, liability, claim}
{financial, litigation, operation}
{product, market, service}
{customer, product, revenue}
{acquisition, growth, future}
{operation, international, foreign}
{personnel, key, retain}
{interest, director, officer}
{property, intellectual, protect}
{debt, indebtedness, cash}
{regulation, government, change}
SUBSTANTIALLY ALL OF OUR REVENUES ARE DERIVED FROM SALES OF ONE PRODUCT LINE. WE MAY FACE UNCERTAINTIES WITH RESPECT TO THE EXECUTION, COST AND ULTIMATE OUTCOME OF CLOSURE I. WE FACE UNCERTAINTIES WITH RESPECT TO THE AVAILABILITY OF THIRD-PARTY REIMBURSEMENT. WE MAY FACE UNCERTAINTIES WITH RESPECT TO COMMERCIALIZATION, PRODUCT DEVELOPMENT AND MARKET ACCEPTANCE OF OUR PRODUCTS. AS A RESULT OF GOVERNMENT REGULATIONS, WE MAY EXPERIENCE LOWER SALES AND EARNINGS. REVENUE GENERATED BY CARS IDE MAY BE LIMITED. OUR MANUFACTURING OPERATIONS AND RELATED PRODUCT SALES MAY BE ADVERSELY AFFECTED BY A REDUCTION OR INTERRUPTION IN SUPPLY AND AN INABILITY TO OR DELAYS IN DEVELOPING ALTERNATIVE SOURCES OF SUPPLY. WE MAY FACE CHALLENGES IN EXECUTING OUR FOCUSED BUSINESS STRATEGY. WE MAY NEED TO RAISE DEBT OR EQUITY FUNDS IN THE FUTURE. WE MAY FACE UNCERTAINTIES WITH RESPECT TO THE EXECUTION, COST AND ULTIMATE OUTCOME OF MIST. WE MAY BE UNABLE TO PROTECT OUR INTELLECTUAL PROPERTY RIGHTS AND MAY FACE INTELLECTUAL PROPERTY INFRINGEMENT CLAIMS. WE RELY ON A SMALL GROUP OF SENIOR EXECUTIVES, AND INTENSE INDUSTRY COMPETITION FOR QUALIFIED EMPLOYEES COULD AFFECT OUR ABILITY TO ATTRACT AND RETAIN NECESSARY, QUALIFIED PERSONNEL. OUR LIMITED MANUFACTURING HISTORY AND THE POSSIBILITY OF NON-COMPLIANCE WITH MANUFACTURING REGULATIONS RAISE UNCERTAINTIES WITH RESPECT TO OUR ABILITY TO COMMERCIALIZE FUTURE PRODUCTS. WE MAY BE UNABLE TO SUCCESSFULLY GROW OUR PRODUCT REVENUES OR EXPAND GEOGRAPHICALLY DUE TO LIMITED MARKETING AND SALES EXPERIENCE. WE MAY BE UNABLE TO COMPETE SUCCESSFULLY BECAUSE OF INTENSE COMPETITION AND RAPID TECHNOLOGICAL CHANGE IN OUR INDUSTRY. AN ADVERSE OUTCOME IN ANY LITIGATION WE ARE CURRENTLY INVOLVED IN COULD AFFECT OUR FINANCIAL CONDITION. PRODUCT LIABILITY CLAIMS, PRODUCT RECALLS AND UNINSURED OR UNDERINSURED LIABILITIES COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS. OUR EXPANDING EUROPEAN OPERATIONS EXPOSE US TO RISK INHERENT IN FOREIGN OPERATIONS.

Full 10-K form ▸

related documents
811669--2/23/2007--UST_INC
816284--2/18/2010--CELGENE_CORP_/DE/
1050007--11/29/2007--NUTRACEUTICAL_INTERNATIONAL_CORP
1017259--3/29/2010--NMT_MEDICAL_INC
1013606--3/16/2006--ENDOLOGIX_INC_/DE/
1006195--6/8/2009--MATRIXX_INITIATIVES_INC
874716--2/27/2008--IDEXX_LABORATORIES_INC_/DE
1050007--11/23/2010--NUTRACEUTICAL_INTERNATIONAL_CORP
793279--9/11/2008--CANDELA_CORP_/DE/
1013606--3/12/2007--ENDOLOGIX_INC_/DE/
1030206--2/3/2009--VASCULAR_SOLUTIONS_INC
1030206--2/5/2008--VASCULAR_SOLUTIONS_INC
1068874--10/12/2006--IMPLANT_SCIENCES_CORP
1030206--2/2/2010--VASCULAR_SOLUTIONS_INC
1050007--11/20/2008--NUTRACEUTICAL_INTERNATIONAL_CORP
811669--2/24/2006--UST_INC
879682--3/28/2006--PLC_SYSTEMS_INC
793279--9/13/2006--CANDELA_CORP_/DE/
793279--9/13/2007--CANDELA_CORP_/DE/
882873--9/20/2007--UROLOGIX_INC
1091596--2/26/2007--CYTOMEDIX_INC
776008--3/14/2006--STAR_SCIENTIFIC_INC
350907--3/16/2006--THORATEC_CORP
884909--3/17/2008--HOME_DIAGNOSTICS_INC
1017259--3/12/2007--NMT_MEDICAL_INC
918112--8/31/2009--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/
918112--9/28/2010--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/
930184--3/2/2009--VALEANT_PHARMACEUTICALS_INTERNATIONAL
884909--3/23/2007--HOME_DIAGNOSTICS_INC
203077--2/28/2007--ST_JUDE_MEDICAL_INC